The FDA has recalled more than 13,000 bottles of metoprolol succinate
extended-release tablets manufactured by Dr. Reddy’s Laboratories,
Reuters reported. In addition, the agency recently recalled another
lot of generic metoprolol from a different company, Wockhardt. Both
recalls were for medicines manufactured at facilities in India.
The recalls were categorized as Class II, which the FDA says “may
cause temporary or medically reversible adverse health consequences or
where the probability of serious adverse health consequences is remote.”
If you are prescribed metoprolol, a beta blocker, please talk with your doctor.
New York Times story